Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.

Alexandra Cossio Duque, a clinical and community research coordinator from Colombia, has travelled the world to study how to overcome social and geographic barriers to healthcare access. Today, she is working in her home country to strengthen the capacity of health systems to treat leishmaniasis, a neglected tropical disease that is endemic to rural areas of Colombia.

New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Shanelle Gabriel was diagnosed with lupus — a chronic autoimmune disease that mostly affects women of African American and Hispanic descent — while she was at college. Today, as a singer, poet and advocate, she uses her voice to highlight challenges faced by people living with this complex and often misunderstood condition.

Photos: Brent Stirton, Getty Images for Novartis

Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery.

Patients are learning to live with a chronic disease that will affect one in 5 people over age 40.

Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.